AEON Q4 2025 Earnings Deep EPS Miss Amid PreRevenue Stage NCMI Q1 2026 Earnings WiderThanExpected Loss Weighs on Investor Sentiment WHLRP Q2 2024 Earnings Positive EPS Reported Amid Stock Decline CYN Q1 2026 Earnings EPS Surprise of 264 Highlights Cost Discipline Amid Revenue Void Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress ENVB Q4 2024 Earnings EPS Misses Estimates No Revenue Reported